Biovica International AB
556774-6150ActiveDeveloping blood tests to monitor cancer treatment efficacy.
Biotech Companybiovica.com
Översikt
- 10–19
- Anställda
- 20–50milj SEK
- Omsättning
- 2009
- Grundat
Nyckelbeslutsfattare
Rickard Boman
VP R&D and Production
Sofia Löhman
VP QA/RA
Anders Rylander
CEO
Fredrik Alpsten
Chair & Board Member – Audit Committee
+5 fler kontakter i Funnelfeedr
Beskrivning
Biovica International AB is a Swedish biotech company established in 2009. Its core mission is to transform cancer care management through innovative biomarker-based tests. The company specializes in developing and commercializing novel blood-based assays, such as the DiviTum® TKa test. This specifi...